The life science group Sartorius is launching an integrated system for the production and quality control (QC) of autologous cell therapies.
ImmunityBio (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced the successful completion of manufacturing engineering programs, NK2022 and NK2023, establishing a safe, ...
Asahi Kasei, a diversified global company, Nippon Steel, and Nippon Steel Trading have launched a recycling initiative to convert pure titanium scrap generated during the manufacturing of electrolysis ...
Recent advances in cell culture technology have transformed the landscape of viral vaccine production, offering enhanced scalability, efficiency and adaptability compared to traditional egg‐based or ...
NeuroScientific Biopharmaceuticals has begun transferring the production of stem cells for its StemSmart therapy to Q-Gen in Brisbane, ahead of Crohn’s disease clinical trials.
Researchers at École Polytechnique Fédérale de Lausanne (EPFL) and Center Suisse d’Electronique et de Microtechnique (CSEM) in Switzerland developed a novel single-step thermal annealing process for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results